Saturday, November 27, 2021
Home Tags Clinical Trial

Tag: Clinical Trial

Clinical trials of Nasal Spray for COVID-19 prevention started

Diversified entity ITC on Thursday confirmed that it is developing a nasal spray for COVID-19 prevention for which it has initiated clinical trials.

CDSCO Panel gives nod to Sun Pharma’s Dapagliflozin, Glimepiride, Metformin FDC

New Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...

New drug combination highly beneficial in children with leukaemia

A Phase III clinical trial conducted by the Children’s Oncology Group has shown a drug combination to be highly effective in children...

Anti-Covid drug manufacturers move to CDSCO for permission

NEW DELHI:  Hopes have risen for the approval of the first Covid-19 antiviral drug in India with two drug makers reaching the...

Dr Reddy’s to launch Clinical Trials of single dose Sputnik Light...

Dr Reddy's on Friday said it plans to launch separate clinical trials of the single shot Sputnik Light vaccine on children as well as using it as...

Medicine For Dengue: डेंगू से नहीं जाएगी जान, जल्द होगा Clinical...

डेंगू से लोगों की जान बचाने के लिए तैयार की गई दवा का क्लीनिकल ट्रायल एसएन मेडिकल कालेज में भी होगा।

AstraZeneca launches Clinical Trial Data division in India

Drug firm AstraZeneca on Wednesday said it has launched a clinical data and insights division in India for data-related management of its...

Biological E seeks DCGI nod for phase-3 trial for Booster dose

The Hyderabad-based Biological E vaccine manufacturing firm has recently sought the nod of Central drug regulator Drug Controller General of India (DCGI)...

Biological E seeks DCGI nod for Phase-III trial of Corbevax

Biological E has sought permission from India’s drug regulator to conduct the phase-III clinical trial for its C-19 vaccine Corbevax as a...

Bharat Biotech submits Clinical Trial data to CDSCO for Covaxin in...

HYDERABAD: Bharat Biotech, which completed the Phase 2/3 trials of C-19 vaccine Covaxin for use in children under 18 years of age, has submitted the...

CDSCO to start BA/BE studies registration process online from Oct 15

The national drug regulator will be switching the applications for registration of centres for bioavailability / bioequivalence (BA/BE) studies from the industry,...

DCGI gives permission to conduct Phase III trial for two-dose C-19...

India’s drug regulator Drugs Controller General of India (DCGI) has given permission to Zydus Cadila for conducting Phase III trial on the two-dose regimen...

Covaxin kids trial over: Data to be submitted to DCGI

HYDERABAD: Bharat Biotech, the developer of indigenously developed C-19 vaccine Covaxin, has completed the Phase II/III trials on children in the 2-18 years age...

WHO emergency use authorisation to Covaxin delayed till October 5

New Delhi : World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to C-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech,...

CDRI completes Clinical trial of Anti Viral Drug ‘Umifenovir’ for C-19

LUCKNOW: The Central Drug Research Institute (CDRI) has claimed to have developed an indigenous anti-viral drug– Umifenovir—for the treatment of C-19. Lucknow-based...

Sanofi provides update on Phase III Trial of Rilzabrutinib

The phase-III Pegasus trial evaluating Rilzabrutinib to treat pemphigus, a rare autoimmune skin condition, did not meet its primary or key secondary...

USFDA updates norms to conduct Human studies

The USFDA, concerned on the safety of clinical trial subjects during the pandemic, has updated its March 2020 norms on conducting human...

DCGI gives nod for Vaccine’s phase-II/III trials on kids aged between...

The Drugs Controller General of India (DCGI) yesterday granted permission to Hyderabad-based Biological E to conduct phase-II/III clinical trials of its ‘Made...

Novel antibiotic Nafithromycin for respiratory track infection

Wockhardt Bio AG and Jemincare have partnered for Wockhardt’s novel patented antibiotic WCK 4873 (INN: Nafithromycin) in People’s Republic of China, Hong...

Nasal Vaccine gets DCGI nod for Phase II, III trials: Bharat...

The first nasal vaccine against C-19, developed by Bharat Biotech, has received the DCGI’s nod for conducting phase-II and -III clinical trials,...

First Nasal Vaccine gets nod for Phase 2 trial: Bharat Biotech

New Delhi: The first nasal vaccine against C-19, developed by Bharat Biotech, has received regulator’s nod for conducting phase 2 clinical trial, the...

SII writes to Govt proposing reforms in Drug Regulatory System

NEW DELHI: World's largest vaccine manufacturer by volume, Serum Institute of India (SII) has written to Union Health Minister Mansukh Mandaviya suggesting...

Brazil suspends Clinical Trials of Bharat Biotech’s Covaxin

Brazil has suspended the clinical trials of Bharat Biotech's C-19 vaccine, Covaxin after the Hyderabad based company terminated agreement with its partner...

Vaccine for Kids to be available soon: Govt

The Union government on Friday told the Delhi high court that C-19 vaccines for children below the age of 18 years will...

Latest posts

High Court restrains publishing Ads in a dispute on Chyawanprash

The Calcutta High Court has issued an interim injunction restraining Shree Baidyanath Ayurved Bhawan Pvt Ltd from issuing certain print and video...

Authors

58 POSTS0 COMMENTS
30 POSTS0 COMMENTS
20 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS